Abstract
Ivermectin is the mainstay of onchocerciasis control. However, it has been discovered that it can induce severe adverse reactions in some individuals. Hence, this model is used to assess the impact of adverse reactions that may occur upon uptake of ivermectin on the control of onchocerciasis. Numerical study of the model shows that the fraction of infectious humans who may refuse to continue with treatment due to the experience of a severe adverse effect as well as the severe adverse reaction induced death rate has significant impact on the dynamics of the model. The adverse reaction induced death rate of infectious humans who may refuse to continue with treatment due to the experience of a severe adverse effect was shown to cause a backward bifurcation. Also, an increase in the fraction of infectious humans who may refuse to continue with treatment due to the experience of an adverse drug effect was shown to increase the backward bifurcation range. Numerical simulation of the optimal control model show that the use of both mass administration of ivermectin and vector control strategies will accelerate the achievement of onchocerciasis elimination.
Similar content being viewed by others
Data Availability
The data that support the findings of this study are available in 1. https://www.who.int/data/gho/data/indicators/indicator-details/GHO/reported-number-of-individuals-treated-for-onchocerciasis 2. https://bmcpharmacoltoxicol.biomedcentral.com/articles/10.1186/s40360-019-0327-5.
References
Amazigo U, Noma M, Bump J, Bentin B, Liese B, Yameogo L, Zour\(\acute{e}\) H, Seketeli A (2006) Onchocerciasis disease and mortality in sub Saharan Africa, Chapter 15, World Bank, Washington, DC
Bof Makenga JM, Tshitoka FN, Muteba D, Mansiangi P, Coppieters Y (2019) Review of the national program for onchocerciasis control in the democratic Republic of the Congo. Trop Med Infect Dis 4:92
Kuesel AC (2016) Research for new drugs for elimination of onchocerciasis in Africa. Int J Parasitol Drugs Drug Resist 6:272–286
White G (1991) The natural history of blackflies. Med Vet Entomol 5(2):192
Campillo JT, Boussinesq M, Bertout S, Faillie J-L, Chesnais CB (2021) Serious adverse reactions associated with ivermectin: a systematic pharmacovigilance study in sub-Saharan Africa and in the rest of the World. PLoS Neglect Trop Dis 15(4):e0009354. https://doi.org/10.1371/journal.pntd.0009354
World Health Organization (2018) Onchocerciasis-river blindness. Fact Sheet No. 95
Shirey RJ, Globisch D, Eubanks LM, Hixon MS, Janda KD (2018) Noninvasive Urine biomarker lateral flow immunoassay for monitoring active onchocerciasis. ACS Infect Dis 4:1423–1431
Bof Makenga JM, Maketa V, Bakajika DK, Ntumba F, Mpunga D, Murdoch ME, Hopkins A, Noma MM, Zoure H, Tekle AH, Katabarwa MN, Lutumba P (2015) Onchocerciasis control in the Democratic Republic of Congo (DRC): challenges in a post-war environment. Trop Med Int Health 20:48–62
Bof Makenga JM, Muteba D, Mansiangi P, Ilunga-Ilunga F, Coppieters Y (2019) Analysis of severe adverse effects following community-based ivermectin treatment in the Democratic Republic of Congo. BMC Pharmacol Toxicol 420:49
Dimomfu BL, Lubeji DK, Noma M, Beketeli A, Boussines M (2007) Sociological study in three foci of Central Africa before the implementation of treatments with ivermectin (Mectizan). APOC Trans R Soc Trop Med Hyg 101:674–9
World Health Organisation (WHO) (2018) African Program for Onchocerciasis Control (APOC). Community-directed treatment with ivermectin (CDTI)
Haselow NJ, Akame J, Evini C, Akongo S (2003) Programmatic and communication issues in relation to serious adverse events following ivermectin treatment in areas Co-endemic for onchocerciasis and loiasis. Filaria. J. 2 (Suppl. 1), S10
National Program for Onchocerciasis Control (NPOC). Annual technical report of the National Coordination Group for onchocerciasis (NCGO) Kasai occidental project. Kinshasa, DRC. 2002;2002:1–50
National Program for Onchocerciasis Control (NPOC). Annual technical report of the National Coordination Group for onchocerciasis (NCGO). Bas Uel\(\acute{e}\) project, Kinshasa, DRC. 2009;2009:1–50
Kamgno J, Pion SD, Tejiokem MC, Twum-Danso NA, Thylefors B, Boussinesq M (2007) Randomized, controlled, double-blind trial with ivermectin on Loa loa microfilaraemia: efficacy of a low dose (approximately 25 microg/kg) versus current standard dose (150 microg/kg). Trans R Soc Trop Med Hyg 101:777–85
Omondi EO, Nyabadza F, Bonyah E, Badu K (2017) Modeling the infection dynamics of onchocerciasis and its treatment. J Biol Syst 25(2):247–277
Omondi EO, Orwa TO, Nyabadza F (2017) Application of optimal control to the onchocerciasis transmission model with treatment. Math Biosci 297:43–57
Hassan A, Shaban N (2020) Onchocerciasis dynamics: modelling the effects of treatment, education and vector control. J Biol Dyn 14(1):245–268. https://doi.org/10.1080/17513758.2020.1745306
Diekmann O, Heesterbeek JAP (2000) Mathematical epidemiology of infectious diseases: model building, analysis and interpretation. Wiley, New York
van den Driessche P, Watmough J (2002) Reproduction number and sub-threshold endemic equilibria for computational models of disease transmission. Math Biosci 180:29–48
La Salle JP (1976) The stability of dynamical systems, Regional Conference Series in Applied Mathematics. SIAM Philadephia
Smith Morgan E, Bilal Shakir, Lakwo Thomson L, Habomugisha Peace, Tukahebwa Edridah, Byamukama Edson, Katabarwa Moses N, Richards Frank O, Cupp Eddie W, Unnasch Thomas R, Michael Edwin (2019) Accelerating river blindness elimination by supplementing MDA with a vegetation slash and clear vector control strategy: a data-driven modeling analysis Scientific Reports 9:15274
Tirados I, Thomsen E, Worrall E, Koala L, Melachio TT, Bas\(\acute{a}\tilde{n}\)ez M (2022) Vector control and entomological capacity for onchocerciasis elimination. Trends in Parasitology. 38(7)
Lakwo T, Oguttu D, Ukety T, Post R, Bakajika D (2020) Onchocerciasis Elimination: Progress and Challenges. Res Rep Trop Med 7(11):81–95
Raimon S, Lakwo TL, Sebit WJ, Siewe Fodjo JN, Alinda P, Carter JY, Post RJ, Colebunders R (2021) Slash and clear, a community-based vector control method to reduce onchocerciasis transmission by simulium sirbanum in Maridi, South Sudan: a prospective study. Pathogens 10(10):1329
Fleming WH, Rishel RW (1975) Deterministic and stochastic optimal control. Springer, New York
Pontryagin L, Boltyanskii V, Gamkrelidze R, Mishchenko E (1963) The mathematical theory of optimal control process 4, New York/London 1962. John Wiley & Sons
Funding
No funding sources
Author information
Authors and Affiliations
Contributions
AN contributed to conceptualization; AN and CO contributed to methodology; AN and CO contributed to qualitative analysis; AN contributed to writing-original draft preparation; AN and DO contributed to writing-review and editing
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Appendix A: Existence of EEP
Appendix A: Existence of EEP
The coefficients of the polynomial equation (5) are given as follows:
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Nwankwo, A., Okereke, C. & Okuonghae, D. Assessing the impact of adverse reactions associated with ivermectin on the dynamics of onchocerciasis in the Democratic Republic of Congo. Int. J. Dynam. Control 12, 1346–1365 (2024). https://doi.org/10.1007/s40435-023-01263-w
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40435-023-01263-w